Decheng Capital China Life Sciences USD Fund III, L.P. sold $20k of BYSI
owner at BeyondSpring Inc.. 11,267 shares at an average of $1.77, traded Sep 17, 2025, filed Sep 19, 2025.
Score components
- +12Role10% owner
- 0Trade size$20k at market
- 0Share of holdings soldSold 0.6% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.8%, 3m +22.4%, 6m -16.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-25-000221, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 17, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -2,304 | $1.83 | $4,216 | 1,868,296 | Sep 19, 2025 |
| Sep 18, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -5,307 | $1.74 | $9,234 | 1,862,989 | Sep 19, 2025 |
| Sep 19, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -3,656 | $1.79 | $6,544 | 1,859,333 | Sep 19, 2025 |
Related signals
Other insiders at BeyondSpring Inc. and this insider’s other filings.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.